Article info

Download PDFPDF

Original research
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma

Authors

  1. Correspondence to Brenda De Keersmaecker; Brenda.Dekeersmaecker{at}etherna.be
View Full Text

Citation

De Keersmaecker B, Claerhout S, Carrasco J, et al
TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma

Publication history

  • Accepted February 11, 2020
  • First published February 28, 2020.
Online issue publication 
January 11, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.